Gregory J. Tryder

Array ( [id] => 6447022 [patent_doc_number] => 20100144812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production Containing an Azole' [patent_app_type] => utility [patent_app_number] => 12/708557 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27461 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144812.pdf [firstpage_image] =>[orig_patent_app_number] => 12708557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663817 [patent_doc_number] => 20110313086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'POLYOXYMETHYLENES FOR DIESEL APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/148727 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6628 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313086.pdf [firstpage_image] =>[orig_patent_app_number] => 13148727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239279 [patent_doc_number] => 08604071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes' [patent_app_type] => utility [patent_app_number] => 13/147648 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7279 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13147648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6450854 [patent_doc_number] => 20100280254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PREPARATION OF A LEAD-FREE PRIMARY EXPLOSIVE' [patent_app_type] => utility [patent_app_number] => 12/691849 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2297 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280254.pdf [firstpage_image] =>[orig_patent_app_number] => 12691849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801268 [patent_doc_number] => 08129540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds' [patent_app_type] => utility [patent_app_number] => 12/691005 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25515 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129540.pdf [firstpage_image] =>[orig_patent_app_number] => 12691005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685069 [patent_doc_number] => 20100121072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Candesartan cilexetil polymorphs' [patent_app_type] => utility [patent_app_number] => 12/657116 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17669 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20100121072.pdf [firstpage_image] =>[orig_patent_app_number] => 12657116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323302 [patent_doc_number] => 20100113798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'PROCESS FOR PREPARATION OF IRBESARTAN' [patent_app_type] => utility [patent_app_number] => 12/683713 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6454 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113798.pdf [firstpage_image] =>[orig_patent_app_number] => 12683713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523117 [patent_doc_number] => 08026273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => '8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient' [patent_app_type] => utility [patent_app_number] => 12/683609 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78726 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026273.pdf [firstpage_image] =>[orig_patent_app_number] => 12683609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231942 [patent_doc_number] => 20100184815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/641954 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64791 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184815.pdf [firstpage_image] =>[orig_patent_app_number] => 12641954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494256 [patent_doc_number] => 20100093735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CYTOKINE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/637714 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87555 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093735.pdf [firstpage_image] =>[orig_patent_app_number] => 12637714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490629 [patent_doc_number] => 20110237633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/133972 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47562 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237633.pdf [firstpage_image] =>[orig_patent_app_number] => 13133972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487908 [patent_doc_number] => 20110251248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/140260 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23007 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251248.pdf [firstpage_image] =>[orig_patent_app_number] => 13140260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560046 [patent_doc_number] => 08334109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Reagent for blood analysis and method of using the same' [patent_app_type] => utility [patent_app_number] => 12/633452 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 6630 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490631 [patent_doc_number] => 20110237634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'NOVEL CRYSTALLINE FORMS OF AN INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1' [patent_app_type] => utility [patent_app_number] => 13/133516 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4112 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237634.pdf [firstpage_image] =>[orig_patent_app_number] => 13133516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458110 [patent_doc_number] => 08293777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Angiotensin II receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/629419 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8393 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12629419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490461 [patent_doc_number] => 20110237590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'PYRIDINE-3-CARBOXYAMIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/131561 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83047 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237590.pdf [firstpage_image] =>[orig_patent_app_number] => 13131561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375743 [patent_doc_number] => 20100076051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'ISOINDOLINONE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/625958 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30041 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076051.pdf [firstpage_image] =>[orig_patent_app_number] => 12625958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619114 [patent_doc_number] => 20100099888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Process for the preparation of anticancer drugs' [patent_app_type] => utility [patent_app_number] => 12/592066 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7576 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099888.pdf [firstpage_image] =>[orig_patent_app_number] => 12592066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458106 [patent_doc_number] => 08293773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => '1, 2, 3-triazole derivatives as new cannabinoid-1 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/591235 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6236 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12591235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223223 [patent_doc_number] => 20100056591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators' [patent_app_type] => utility [patent_app_number] => 12/591090 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 26334 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056591.pdf [firstpage_image] =>[orig_patent_app_number] => 12591090 [rel_patent_id] =>[rel_patent_doc_number] =>)